Project Grant HT94252510775
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Livermore, CA, USA
Similar Awards
The Department of Defense's Defense Health Agency has awarded a $2,650,080 Project Grant to National Jewish Health, a non-profit hospital and research center in Denver, Colorado. The grant, titled "ROLE OF BURN PIT-RELATED PARTICULATE MATTER IN DRIVING DEPLOYMENT-RELATED LUNG DISEASE," is funded through the Military Medical Research and Development program (CFDA 12.420). The project aims to investigate the impact of exposure to burn pit particulate matter on the development of lung...
The federal Project Grant award of $1,949,901.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Salisbury Foundation For Research And Education, doing business as Hefner Ba Medical Center, on the relationship between blast exposure and cellular senescence in veterans. The award period runs from September 1, 2025 to August 31, 2029. The research aims to investigate the impact of blast exposure on hippocampal volume and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,217,668.00 to the Medstar Health Research Institute Inc. for a research project titled "Toxic Products of Combustion in Burn and Smoke Inhalation Injuries". The performance period runs from September 1, 2024 through October 31, 2027. The Medstar Health Research Institute Inc., a non-profit healthcare research organization, will conduct...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $680,757 project grant to New York University School of Medicine to conduct research titled "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation." The grant, effective July 1, 2025 through June 30, 2028, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
The University of Massachusetts Medical School was awarded a $836,992 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2025, will fund research to investigate the effects of military-associated environmental toxins on motor neurons and glial cells in sporadic amyotrophic lateral sclerosis (ALS). The research aims to transform healthcare for military service members, veterans, and the broader...
The U.S. Department of Defense (DoD) awarded a $784,963 Project Grant to the University of California, Irvine (UC Irvine) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, funds research focused on "Interactions of Fine Particulate Matter Exposure and Gonadal Toxicity on Alzheimer's Disease Progression." UC Irvine, as a leading public research university with expertise across biomedical disciplines, will...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,078,882 to the Sanford Burnham Prebys Medical Discovery Institute to conduct advanced chemical engineering research on amyotrophic lateral sclerosis (ALS). The research aims to take a more sophisticated, multimodal approach to understanding the therapeutic actions of donor and host neural stem cells in ALS. The award includes a sub-grant to the J. David...
The Defense Health Agency awarded a $749,905 Project Grant to The Roskamp Institute Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to investigate microglial NOX2/NLRP3 inflammasome activation and its role in driving tau pathology and cognitive impairments in chronic traumatic brain injury. Specifically, the Roskamp Institute will conduct basic, applied, and advanced biomedical...
The U.S. Department of Defense's Defense Health Agency has awarded a $780,000 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "LEAD EXPOSURE AND SEX-SPECIFIC PROGRAMMING OF CARDIOVASCULAR DISEASE ACROSS THE LIFE COURSE", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate...